[Double-blind clinical study: flunarizine versus pizotifen in a single nightly dose in hemicrania patients]. 1985

R Cerbo, and M Casacchia, and R Formisano, and M G Buzzi, and B Boni, and M Feliciani, and G Grillo, and G Cusimano, and A Agnoli

In this double-blind clinical trial we compared the prophylactic efficacy of the calcium-entry blocker flunarizine (15 mg nocte) with that of pizotifen (1,5 mg nocte). In 30 patients affected by classical and common migraine. During a two months treatment both drugs showed a good efficacy. Flunarizine tended to more markedly suppress severity of pain and duration of attacks than pizotifen. Daytime drowsiness and weight gain occurred with both drugs; the first side effect was more evident in the group treated with flunarizine, the second one in the group treated with pizotifen.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008881 Migraine Disorders A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1) Acute Confusional Migraine,Headache, Migraine,Status Migrainosus,Abdominal Migraine,Cervical Migraine Syndrome,Hemicrania Migraine,Migraine,Migraine Headache,Migraine Variant,Sick Headache,Abdominal Migraines,Acute Confusional Migraines,Cervical Migraine Syndromes,Disorder, Migraine,Disorders, Migraine,Headache, Sick,Headaches, Migraine,Headaches, Sick,Hemicrania Migraines,Migraine Disorder,Migraine Headaches,Migraine Syndrome, Cervical,Migraine Syndromes, Cervical,Migraine Variants,Migraine, Abdominal,Migraine, Acute Confusional,Migraine, Hemicrania,Migraines,Migraines, Abdominal,Migraines, Acute Confusional,Migraines, Hemicrania,Sick Headaches,Variant, Migraine,Variants, Migraine
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D010918 Pizotyline Serotonin antagonist used against MIGRAINE DISORDERS and vascular headaches. Pizotifen,BC-105,Polomigran,Sandomigran,BC 105,BC105
D002936 Cinnarizine A piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS. 1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine,Cinarizina Inkey,Cinarizina Ratiopharm,Cinarizine,Cinazière,Cinna,Cinnarizin AL,Cinnarizin Siegfried,Cinnarizin Von Ct,Cinnarizin-Ratiopharm,Cinnarizine L-Tartrate,Cinnarizine L-Tartrate (1:1),Cinnarizine, (E)-Isomer,Cinnarizine, Dihydrochloride,Cinnipirine,Cisaken,Dimitronal,R-516,Stugeron,Stugeron Forte,Cinnarizin Ratiopharm,Cinnarizine L Tartrate,Dihydrochloride Cinnarizine,L-Tartrate, Cinnarizine,R 516,R516,Von Ct, Cinnarizin
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005444 Flunarizine Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. Flunarizin,Flunarizine Dihydrochloride,Flunarizine Hydrochloride,R-14950,Sibelium,Dihydrochloride, Flunarizine,Hydrochloride, Flunarizine,R 14950,R14950
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Cerbo, and M Casacchia, and R Formisano, and M G Buzzi, and B Boni, and M Feliciani, and G Grillo, and G Cusimano, and A Agnoli
February 1986, Headache,
R Cerbo, and M Casacchia, and R Formisano, and M G Buzzi, and B Boni, and M Feliciani, and G Grillo, and G Cusimano, and A Agnoli
December 1982, Cephalalgia : an international journal of headache,
R Cerbo, and M Casacchia, and R Formisano, and M G Buzzi, and B Boni, and M Feliciani, and G Grillo, and G Cusimano, and A Agnoli
July 1983, MMW, Munchener medizinische Wochenschrift,
R Cerbo, and M Casacchia, and R Formisano, and M G Buzzi, and B Boni, and M Feliciani, and G Grillo, and G Cusimano, and A Agnoli
January 1987, Drugs,
R Cerbo, and M Casacchia, and R Formisano, and M G Buzzi, and B Boni, and M Feliciani, and G Grillo, and G Cusimano, and A Agnoli
January 1988, International journal of clinical pharmacology research,
R Cerbo, and M Casacchia, and R Formisano, and M G Buzzi, and B Boni, and M Feliciani, and G Grillo, and G Cusimano, and A Agnoli
February 2010, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons,
R Cerbo, and M Casacchia, and R Formisano, and M G Buzzi, and B Boni, and M Feliciani, and G Grillo, and G Cusimano, and A Agnoli
October 1977, Diseases of the nervous system,
R Cerbo, and M Casacchia, and R Formisano, and M G Buzzi, and B Boni, and M Feliciani, and G Grillo, and G Cusimano, and A Agnoli
June 1999, Headache,
R Cerbo, and M Casacchia, and R Formisano, and M G Buzzi, and B Boni, and M Feliciani, and G Grillo, and G Cusimano, and A Agnoli
March 1990, La Clinica terapeutica,
R Cerbo, and M Casacchia, and R Formisano, and M G Buzzi, and B Boni, and M Feliciani, and G Grillo, and G Cusimano, and A Agnoli
December 1992, La Clinica terapeutica,
Copied contents to your clipboard!